0000000000568001

AUTHOR

Martin Schostak

showing 2 related works from this author

Non-muscle invasive bladder cancer: Are epicrises the ‘Bermuda Triangle’ of information transfer?

2017

Introduction The aim of the study was to collect information regarding the quality of communication of risk-determining factors or risk profile, and the guideline conformity of recommendations for adjuvant treatment in patients with non-muscle invasive bladder cancer (NMIBC) between clinical and ambulatory urologists. Material and methods At three German urological clinics during the period between 2012-2014, epicrises of 1,033 NMIBC-patients were retrospectively summarised to 505 tumour episodes (tumour resection including any re-resections) and analysed regarding the endpoints 1) risk profile is explicitly named or recorded risk factors are sufficient for the determination of risk profile…

medicine.medical_specialtyOriginal PaperProcess Assessment (Health Care)Bladder cancerbusiness.industryTumor resection030232 urology & nephrologyGuideline complianceGuideline adherenceGeneral MedicineGuidelinemedicine.diseaseLogistic regression03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisInternal medicineGermanyAmbulatorymedicineIn patientNon muscle invasivebusinessurinary bladder neoplasmsCentral European Journal of Urology
researchProduct

Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Large Multicenter Cohort Study.

2020

Focal therapy (FT) with its favorable side-effect profile represents an option between active surveillance and traditional whole-gland treatment in localized prostate cancer (PCa). Consensus statements recommend eligibility criteria based on magnetic resonance imaging (MRI)-targeted and systematic combination biopsy.To estimate the future potential of FT by analyzing the number of men eligible for FT among all men with biopsy-proven PCa and to judge the potential of different energy sources.Consensus criteria on FT were analyzed. Patients with biopsy-proven PCa from six tertiary referral hospitals and one outpatient practice in Germany had received a software-based combination biopsy. Men w…

Malemedicine.medical_specialtyProstate biopsyUrologyBiopsy030232 urology & nephrologyCohort Studies03 medical and health sciencesProstate cancer0302 clinical medicineProstateBiopsyMedicineHumansmedicine.diagnostic_testbusiness.industryProstatic NeoplasmsMagnetic resonance imagingProstate-Specific Antigenmedicine.diseaseMagnetic Resonance Imagingmedicine.anatomical_structure030220 oncology & carcinogenesisProstate neoplasmRadiologybusinessEnergy sourceCohort studyEuropean urology focus
researchProduct